Hikal Ltd
NSE:HIKAL
Hikal Ltd
NSE:HIKAL
Price:
208.04
INR
-0.76%
Market Closed
Market Cap:
₹25.7B
Relative Value
The Relative Value of one
HIKAL
stock under the Base Case scenario is
hidden
INR.
Compared to the current market price of 208.04 INR,
Hikal Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
HIKAL Relative Value
HIDDEN
Multiples Across Competitors
HIKAL Competitors Multiples
Hikal Ltd Competitors
Hikal Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Hikal Ltd
NSE:HIKAL
|
25.7B INR | 1.5 | 254 | 12.4 | 36.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1T USD | 15.3 | 48.3 | 32.6 | 34.6 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
584.7B USD | 6.2 | 21.9 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
291.9B CHF | 4.8 | 31.1 | 13.1 | 15.3 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
238.4B GBP | 5.6 | 32.1 | 17.7 | 24.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
246.5B CHF | 5.6 | 22.7 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.7B USD | 4.7 | 16.6 | 10.3 | 12.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.5 | 13.4 | 9.8 | 11.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
157.8B USD | 2.5 | 20.2 | 7.5 | 10 | |
| UK |
|
GSK plc
XETRA:GS71
|
104B EUR | 2.8 | 15.8 | 8 | 11.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
